product description: UVI 3003 is a highly selective antagonist of retinoid X receptor (RXR), and inhibits xenopus and human RXRα with IC50 of 0.22 μM and 0.24 μM in Cos7 cells, respectively.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
UVI 3003
CAS number:847239-17-2 molecular formula:C28H36O4
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | BS-17614 | AKOS024457539 | SCHEMBL19119381 | GTPL2816 | compound 10e [PMID: 19408900] | (2E)-3-{4-hydroxy-3-[5,5,8,8-tetramethyl-3-(pentyloxy)-5,6,7,8-tetrahydronaphthalen-2-yl]phenyl}prop-2-enoic acid | Q27089116 | UVI3003 | UVI-3003 | (E)-3-[4-hydroxy-3 | ||
| CAS number | 847239-17-2 | molecular formula | C28H36O4 |
| molecular weight | 436.58 g/mol | Exact mass | - |
| PSA | 66.800 Ų | logp | 8.000 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





